mice to LPS 0113 in greater detail. Because one could argue that the antibody response produced may be directed against lipid-A-associated protein found in some preparations of LPS (15) (16) (17) , only LPS prepared by the phenol-water extraction procedure (18) was used; such preparations are considered to be free of contaminating lipoprotein (16, 17) . Also, to establish that the antibody response of xid mice is specific for the O-polysaccharide moiety of LPS, the native protoplasmic polysaccharide (NPP) of E. coli 0113 was used to prime mice for a secondary antibody response to LPS 0113, as well as to inhibit the detection of antibody-producing plaque-forming cells (PFC) found after immunization with LPS 0113. NPP is a simple polysaccharide product of aberrant bacterial metabolism; it is free of lipid A but, in mice, behaves as an antigen with specificity for LPS 0113 (19, 20) Recently, we derived a series of hybridomas that make monoclonal antibodies specific for LPS 0113; these monoclonal antibodies share a cross-reactive idiotype (IdX) expressed on LPS 0113-specific antibodies of all strains of mice examined (21) . The expression of this IdX, which is neither allotype-nor major histocompatibility complex-restricted, also was examined for CBA/N mice immunized with LPS 0113.
Materials and Methods
Animals. BALB/cCum mice were purchased from Cumberland View Farms, Clinton, TN. C3H/HeJ and CBA/CaJ mice were purchased from The Jackson Laboratory, Bar Harbor, ME. CBA/N (xid mice) as well as C3H/HeN-MTV + mice were obtained from the Small Animal Section, Veterinary Resources Branch, Division of Research Services, National Institutes of Health, Bethesda, MD. Only female mice, 6-8 wk old, were used in this work.
Antigens and Immunization Procedure. LPS 0113 was extracted from the cell walls of E. coil 0113 (Braude) by the phenol-water method (18) . Details concerning its preparation, as well as its immunological properties, have been described (22) ; there is ample evidence to indicate that LPS 0113 is a TI antigen (20, (23) (24) (25) . NPP was extracted with cold trichloroacetic acid (26) from the protoplasmic fraction of E. coli 0113 (Braude). Mice were immunized intraperitoneally with stated amounts of either LPS 0113 or NPP in 0.2 ml saline.
Immunological Methods. Antibody-producing PFC-making antibody specific for LPS 0113 were detected by a slide version of the technique of localized hemolysis-in-gel using sheep erythrocytes (SRBC) sensitized with LPS 0113 as indicator cells (27) . The results obtained for individual mice (PFC per spleen), which are log-normally distributed (28) , are expressed as log10 PFC per spleen + SEM for groups of similarly treated mice. In all cases, corrections were made by subtraction of the number of SRBC-specific background PFC found so that only values for LPS 0113-specific PFC are considered in this work.
A plaque-inhibition test was used to establish that the antibody produced by PFC detected after immunization with LPS 0113 is directed against the O-polysaccharide determinants of LPS 0113. Here, different amounts of LPS 0113 or NPP were added to the agarose-reaction mixture as inhibitors before assay for PFC. The percentage of PFC inhibited was then calculated with reference to control samples that contained no inhibitor.
Numbers of LPS 0113-specific PFC-secreting antibody possessing an IdX also were determined by a plaque-inhibition assay in which 50/zl of dilute (1:100) anti-IdX serum was added to the reaction mixture before the assay for PFC. The antiserum was prepared by immunizing (C.B20 X BALB/c)F~ mice with affinity-purified monoclonal antibody specific for LPS 0113 (21) .
Proliferative Response of Spleen Cells to LPS 011.3. Spleens from nonimmunized mice were removed aseptically and placed in Hanks' balanced salt solution supplemented with 5% fetal calf serum. Cell suspensions were prepared and then adjusted to the desired cell density before culture in Statistics. Student's t test was used to assess the significance of the differences observed.
Differences were considered to be significant when P values <0.05 were obtained. Table I show that LPS 0113 does not induce a significant (P > 0.05) proliferative response in spleen cells from LPS-resistant C3H/HeJ mice. By contrast, it stimulates substantial (P < 0.05) proliferative responses, at doses of 1.25-2.5/Lg, in spleen cells from LPS-sensitive C3H/HeN-MTV +, BALB/cCum, and CBA/N mice. Because spleen cells from C3H/ HeJ mice can give a proliferative response to lipid-A-associated protein but not to purified LPS (15) (16) (17) , these findings affirm that the preparation of LPS 0113 used, prepared by the phenol-water method (18), does not contain significant amounts, if any, of lipid-A-associated protein. The lower proliferative responses of spleen cells from CBA/N mice most likely are due to a lower percentage of B cells present (11) .
Results

Proliferative and Primary Antibody Responses to LPS 0113. The data in
CBA/N mice given a single intraperitoneal injection of 20 ~g LPS 0113 produce a reasonably good primary PFC response 4 d after immunization (Table II) . Although the magnitude of the PFC response produced was less than that of histocompatible CBA/CaJ mice (P < 0.05) in this particular experiment, the percentage of IdX ÷ PFC detected was the same for both strains of mice (P > 0.05); thus, the expression of this IdX is not affected in xid mice. The results of the plaque-inhibition test were similar for both strains of mice (Table  III) . The addition of 50-100/*g LPS 0113 inhibited the detection of virtually all PFC present, whereas the addition of 50-100/_tg NPP gave 70-80% inhibition. The degree of inhibition noted with NPP appeared to be lower than that obtained with LPS 0113. However, this could be attributed to the fact that NPP has a lower molecular size and epitope density (19, 20) ; thus, larger amounts of NPP might be required for complete inhibition. Nevertheless, these findings confirm that the antibody produced after immunization with LPS 01 13 is directed mainly against the O-polysaccharide determinant of LPS 0113, rather than the lipid-A-associated protein or some other component not present in NPP. these findings, in addition to those of T a b l e III, strongly suggest that (a) the antibody response produced is directed against the polysaccharide moiety of LPS 0113 rather than lipid-A-associated protein, and that (b) priming with N P P can prepare C B A / N , as well as other strains of mice (20) , to give a secondary or increased antibody response to LPS 0113. W h e n C B A / N mice were h y p e r i m m u n i z e d (i.e., given three weekly injections of LPS 0113) before i m m u n i z a t i o n with 10 ~g LPS 0113, the response produced was less (P < 0.05) than that for a primary response (Table IV) . H y p e r i m m u n i z e d CBA/CaJ mice gave a response similar in m a g n i t u d e to that for a primary response (Table II) , whereas B A L B / c C u m mice gave an increased response (data not shown). Thus, repeated exposure ofxid mice to LPS 0113 may result in a reduction in their capacity to make an antibody response to this antigen. (Table V) showed that the m a g n i t u d e of the PFC response increased with the dose of LPS 0113 used for i m m u n i z a t i o n ; maximal n u m b e r s of PFC were detected in mice i n m m n i z e d with 10-40/zg of antigen. In studies using other strains of mice (27) , 20 #g of LPS 01 13 also was found to be optimal for immunization.
Dose-Response and Kinetic Studies for the Antibody Response of C B A / N Mice to LPS
Larger doses of LPS 0113 were not given to CBA/N mice because amounts >40/~g were found to be too toxic for most strains of mice considered thus far (27) .
The kinetics for the development of a PFC response in CBA/N mice given an optimally immunogenic dose (20 /tg) of LPS 0113 also was investigated (Fig. 1) . Although maximal numbers of PFC were first detected 3-4 d after immunization, the kinetics for the appearance of PFC showed a cyclic pattern with a periodicity different from that noted with other strains of mice (27) .
Discussion
Studies on the xid of CBA/N mice have provided much information on the differential, as well as functional, aspects of antigen-induced B cell activation (reviewed in references 5 and 32). Because xid mice can make convincing antibody responses to some TI antigens but not others, it has been convenient to view such antigens as being one of two types; TI-1 antigens that elicit an antibody response in xid mice, and TI-2 antigens that do not (5, 11, 13) . It has been proposed that xid mice lack a subpopulation of B cells required for normal antibody responses to TI-2 antigens (reviewed in references 5 and 32).
The inability of xid mice to make an antibody response to preparations of LPS derived from E. coli 0127 (2) and E. coli 0114:B4 (14) led some investigators to conclude that LPS per se are TI-2 antigens, incapable of inducing an antibody response in xid mice (reviewed in references 5 and 32). However, our faith in this generalization began to waiver when the results of preliminary experiments revealed that xid mice can elicit a significant antibody response after immunization with a preparation of LPS derived from E. coli 0113 (LPS 0113). Consequently, we were compelled to examine this response in greater detail to determine whether it is specific for the O-polysaccharide moiety of LPS 0113, or other components present in some preparations of LPS from other sources, isolated by different methods. Of major concern was the possibility that the antibody response made was directed against lipid-A-associated protein.
The preparation of LPS 0113 used in this work has been shown unequivocally to be a TI antigen (20, (23) (24) (25) ; because it was prepared by the phenol-water method, it is thus not likely to contain significant amounts, if any, of lipid-A-associated protein (16, 17) . LPS 0113 produced substantial mitogenic responses in spleen cells from CBA/N, BALB/cCum, and LPS-sensitive C3H/HeN-MTV + mice. However, it stimulated no significant mitogenic responses in spleen cells from LPS-resistant C3H/HeJ mice (Table I) . Furthermore, it induced a convincing PFC response in CBA/N mice (Table II) and virtually all PFC detected could be inhibited by NPP (Table III) , which is free of lipid A as well as lipid-A-associated protein, and contains only the Opolysaccharide moiety of LPS 0113 (19, 33, 34) . LPS-resistant C3H/HeJ mice failed to give convincing primary and secondary antibody responses to LPS 0113 (Table  IV) ; this is consistent with the results of others (27, 30, 31) . However, substantial secondary responses to LPS 0113 were produced in CBA/N mice after priming with either LPS 0113 or NPP (Table IV) . All of the above findings leave no doubt that the antibody response of CBA/N mice immunized with LPS 0113 is specific for the Opolysaccharide moiety of LPS.
CBA/N mice immunized with 20 /lg LPS 0113 make antibody responses that appear to be 20-40% lower than those of histocompatible nondefective CBA/CaJ mice (Tables II and IV) , although dose-response and kinetic studies (Table V; Fig. 1 ) revealed few major differences from the results obtained with other strains of nondefective mice immunized with the same preparation of LPS 0113 (27) . Unlike the results obtained with xid mice immunized with phosphocholine conjugated to keyhole limpet hemocyanin or LPS, in which there is a failure to produce the predominant (T-15) idiotype (35, 36) , there is no change in the expression of a major IdX in CBA/ N mice immunized with LPS 0113 (Table II) . However, hyperimmunization does appear to result in a significant (P < 0.05) decrease in the capacity of CBA/N mice to make an antibody response to this antigen (Table IV) . Obviously, more extensive studies are required to establish whether CBA/N mice are more susceptible than other strains of mice to the induction of immunological tolerance to LPS 0113.
Despite the fact that LPS is considered to be a TI antigen for mice, the ability of CBA/N mice to make an antibody response to some types of LPS, but not others, suggests that it would be unwise to make general statements concerning the immunogenicity of this class of antigens for xid mice. It is well known that some types of LPS are either nonimmunogenic or poorly immunogenic for many strains of mice that do not possess the xid genetic defect (2) . Also, xid mice, as well as several nondefective strains of mice given LPS, can make polyclonal antibody responses (elevated levels of serum Ig) without the synthesis of antibody specific for some types of LPS (2) . Because polyctonal activation and mitogenicity for B cells are usually attributed to the action of lipid A or lipid-A-associated protein in the case of mice given LPS (12, 13) , it is unlikely that immunogenicity per se is determined by these components of the LPS complex. It is more reasonable to assume that the capacity of LPS to induce an antigen-specific antibody response resides in the ability of B cells (a) to recognize the O-polysaccharide moiety of LPS, and/or (b) to become activated with the synthesis and secretion of antibody specific for LPS upon recognition of Opolysaccharide determinants. With regard to the latter, the results of recent studies on the preparation of B cell hybridomas making antibody specific for type III pneumococcal polysaccharide (SSS-III) are most relevant (37) . He,'e, spleen cells from nonresponding xid mice immunized with SSS-III were fused with plasmacytoma cells that do not make antibody specific for SSS-III; genetic complementation occurred as evidenced by the fact that hybridomas making SSS-III-specific antibody were obtained in high frequency. This means that B cells from xid mice possess V region genes involved in the coding of receptors needed for the recognition of SSS-III. However, such cells, even after exposure to SSS-III, lack an internal activation mechanism which permits the synthesis and/or secretion of SSS-III-specific antibody. Although the nature of this activation mechanism remains to be defined, it must involve genes linked to the X-chromosome. Such genes are known to play an important role in the synthesis and/or secretion of IgM (1, 2, 38) , the predominant class of antibody made after immunization with SSS-III (39, 40) . The ability of xid mice to respond to some thymus-independent hapten-carrier conjugates (5, 32) may reflect a means by which an appropriate carrier can bypass to some degree this internal activation mechanism, which may be the major limiting factor in determining IgM antibody responses to antigens such as SSS-III. Obviously, a more complete analysis of the mechanisms involved in the xid genetic defect would add greatly to our knowledge of certain immunodeficiency diseases in man, many of which are X linked. Summary CBA/N mice, which possess an X-linked immunodeficiency (xid), produce a convincing antibody response to lipopolysaccharide derived from Escherichia coli 0113 (LPS 0113), a thymus-independent antigen. The antibody response produced was shown to be specific for the O-polysaccharide moiety of LPS 0113, rather than lipid A or lipid-A-associated protein. The relevance of this finding to the nature of the genetic defect of xid-mice is discussed.
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